A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

NCT01606748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

BIOLOGICAL: Necitumumab
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Eli Lilly and Company